Edition:
United States

OncoGenex Pharmaceuticals Inc (OGXI.OQ)

OGXI.OQ on NASDAQ Stock Exchange Capital Market

0.90USD
22 Jul 2016
Change (% chg)

$-0.02 (-2.17%)
Prev Close
$0.92
Open
$0.95
Day's High
$0.95
Day's Low
$0.90
Volume
10,703
Avg. Vol
46,415
52-wk High
$4.09
52-wk Low
$0.46

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.28 December 24 Jul 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 1 1 1 1
(3) HOLD 2 2 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.25 2.25 2.25 2.25

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 3 0.17 0.50 0.00 --
Quarter Ending Dec-16 3 0.17 0.50 0.00 --
Year Ending Dec-16 3 4.43 5.94 2.90 8.85
Year Ending Dec-17 3 29.08 87.24 0.00 27.65
Earnings (per share)
Quarter Ending Sep-16 3 -0.28 -0.26 -0.30 -0.57
Quarter Ending Dec-16 3 -0.27 -0.25 -0.29 -0.61
Year Ending Dec-16 3 -0.90 -0.83 -0.95 -1.49
Year Ending Dec-17 3 -0.41 1.72 -1.75 0.59

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-16 4.09 2.94 1.15 28.16
Quarter Ending Dec-15 7.69 6.02 1.66 21.64
Quarter Ending Sep-15 7.04 6.74 0.30 4.25
Quarter Ending Jun-15 21.40 4.03 17.38 81.19
Quarter Ending Mar-15 4.66 1.37 3.29 70.54
Earnings (per share)
Quarter Ending Mar-16 -0.12 -0.12 0.00 -2.83
Quarter Ending Dec-15 -0.15 -0.06 0.09 -59.10
Quarter Ending Sep-15 -0.17 -0.16 0.01 -5.88
Quarter Ending Jun-15 0.34 -0.26 0.60 175.74
Quarter Ending Mar-15 -0.34 -0.20 0.14 -41.74

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 0.17 0.17 0.17 0.17 --
Quarter Ending Dec-16 0.17 0.17 0.17 0.17 --
Year Ending Dec-16 4.43 4.43 4.43 4.43 8.85
Year Ending Dec-17 29.08 22.94 22.94 22.94 27.65
Earnings (per share)
Quarter Ending Sep-16 -0.28 -0.28 -0.28 -0.28 -0.57
Quarter Ending Dec-16 -0.27 -0.27 -0.27 -0.27 -0.61
Year Ending Dec-16 -0.90 -0.90 -0.90 -0.90 -1.49
Year Ending Dec-17 -0.41 -0.62 -0.62 -0.62 0.59

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-16 0 0 0 0
Quarter Ending Dec-16 0 0 0 0
Year Ending Dec-16 0 0 0 0
Year Ending Dec-17 0 0 0 0
Earnings
Quarter Ending Sep-16 0 0 0 0
Quarter Ending Dec-16 0 0 0 0
Year Ending Dec-16 0 0 0 0
Year Ending Dec-17 0 0 0 0

Analyst Research Reports

Report Title Price
Provider : ValuEngine, Inc.
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : New Constructs, LLC
$25.00
Provider : Ford Investor Services, Inc.
$12.00
Provider : Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.